Risk factors | HR | 95% CI | p valuea |
---|---|---|---|
Age | |||
≤70 y | 1 | Reference | |
>70 y | 2.29 | 0.87–6.72 | 0.095 |
ECOG PS | |||
0 | 1 | Reference | |
1 | 1.33 | 0.47–3.53 | 0.59 |
Tumor diameter | |||
≤30 mm | 1 | Reference | |
>30 mm | 3.47 | 1.35–8.98 | 0.010 |
VPI | |||
Absent | 1 | Reference | |
Present | 3.18 | 1.11–8.84 | 0.032 |
ALI | |||
Absent | 1 | Reference | |
Present | 1.06 | 0.38–3.15 | 0.91 |
Differentiation | |||
Well | 1 | Reference | |
Moderate/Poor | 1.14 | 0.42–3.01 | 0.80 |
Serum CEA | |||
NN group | 1 | Reference | |
HN group | 2.52 | 0.72–8.11 | 0.14 |
HH group | 7.69 | 2.46–23.7 | < 0.001 |